Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Helmholtz Zentrum München
Múnich, AlemaniaPublicaciones en colaboración con investigadores/as de Helmholtz Zentrum München (13)
2024
2022
-
Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetes
Diabetes/Metabolism Research and Reviews, Vol. 38, Núm. 3
2021
-
O-GlcNAcylated p53 in the liver modulates hepatic glucose production
Nature Communications, Vol. 12, Núm. 1
2020
-
Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma
PLoS ONE, Vol. 15, Núm. 9 September
2019
-
EU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical Biology
SLAS Discovery, Vol. 24, Núm. 3, pp. 398-413
-
Epigenome-wide meta-analysis of DNA methylation and childhood asthma
Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 6, pp. 2062-2074
2018
-
Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility
Nature Communications, Vol. 9, Núm. 1
2016
-
T-and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates
Gene Therapy, Vol. 23, Núm. 10, pp. 753-759
2014
-
Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration
Acta Neuropathologica, Vol. 128, Núm. 3, pp. 397-410
2011
-
Defining the critical hurdles in cancer immunotherapy
Journal of Translational Medicine
2008
-
Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model
Journal of Gene Medicine, Vol. 10, Núm. 2, pp. 177-186
2007
-
Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity
Hepatology, Vol. 45, Núm. 3, pp. 602-613